vs
Bioceres Crop Solutions Corp.（BIOX）与CVR PARTNERS, LP（UAN）财务数据对比。点击上方公司名可切换其他公司
CVR PARTNERS, LP的季度营收约是Bioceres Crop Solutions Corp.的1.7倍（$131.1M vs $77.6M）。CVR PARTNERS, LP净利率更高（-7.8% vs -9.6%，领先1.8%）。CVR PARTNERS, LP同比增速更快（-6.1% vs -16.8%）。过去两年CVR PARTNERS, LP的营收复合增速更高（1.3% vs -8.4%）
Bioceres Crop Solutions Corp是一家全球农业科技企业，研发并商业化耐旱种子性状、生物肥料、生物农药等可持续作物增产解决方案，服务南美、北美、欧洲及亚太地区的农户，致力于提升作物产量，同时降低农业生产的环境影响。
CVR Partners LP是北美领先的氮肥生产商，核心产品包括尿素硝酸铵溶液和氨，主要服务美国与加拿大的农业、工业及商业客户，专注于为作物种植和各类工业应用提供高性价比的养分解决方案。
BIOX vs UAN — 直观对比
营收规模更大
UAN
是对方的1.7倍
$77.6M
营收增速更快
UAN
高出10.7%
-16.8%
净利率更高
UAN
高出1.8%
-9.6%
两年增速更快
UAN
近两年复合增速
-8.4%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $77.6M | $131.1M |
| 净利润 | $-7.4M | $-10.3M |
| 毛利率 | 46.8% | 4.4% |
| 营业利润率 | 9.3% | -2.2% |
| 净利率 | -9.6% | -7.8% |
| 营收同比 | -16.8% | -6.1% |
| 净利润同比 | -20.2% | -156.1% |
| 每股收益（稀释后） | $-0.12 | $-0.98 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIOXUAN
| Q4 25 | — | $131.1M | ||
| Q3 25 | $77.6M | $163.5M | ||
| Q2 25 | — | $168.6M | ||
| Q1 25 | $60.6M | $142.9M | ||
| Q4 24 | $98.8M | $139.6M | ||
| Q3 24 | $93.3M | $125.2M | ||
| Q2 24 | — | $132.9M | ||
| Q1 24 | $84.0M | $127.7M |
净利润BIOXUAN
| Q4 25 | — | $-10.3M | ||
| Q3 25 | $-7.4M | $43.1M | ||
| Q2 25 | — | $38.8M | ||
| Q1 25 | $-1.6M | $27.1M | ||
| Q4 24 | $605.2K | $18.3M | ||
| Q3 24 | $-6.2M | $3.8M | ||
| Q2 24 | — | $26.2M | ||
| Q1 24 | $9.8M | $12.6M |
毛利率BIOXUAN
| Q4 25 | — | 4.4% | ||
| Q3 25 | 46.8% | 37.0% | ||
| Q2 25 | — | 32.4% | ||
| Q1 25 | 39.4% | 29.7% | ||
| Q4 24 | 42.0% | 23.8% | ||
| Q3 24 | 40.2% | 14.7% | ||
| Q2 24 | — | 30.0% | ||
| Q1 24 | 50.8% | 21.4% |
营业利润率BIOXUAN
| Q4 25 | — | -2.2% | ||
| Q3 25 | 9.3% | 31.0% | ||
| Q2 25 | — | 27.5% | ||
| Q1 25 | 1.5% | 24.2% | ||
| Q4 24 | 14.5% | 18.4% | ||
| Q3 24 | 2.5% | 8.8% | ||
| Q2 24 | — | 25.3% | ||
| Q1 24 | 15.7% | 15.7% |
净利率BIOXUAN
| Q4 25 | — | -7.8% | ||
| Q3 25 | -9.6% | 26.3% | ||
| Q2 25 | — | 23.0% | ||
| Q1 25 | -2.6% | 19.0% | ||
| Q4 24 | 0.6% | 13.1% | ||
| Q3 24 | -6.6% | 3.0% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | 11.6% | 9.9% |
每股收益（稀释后）BIOXUAN
| Q4 25 | — | $-0.98 | ||
| Q3 25 | $-0.12 | $4.08 | ||
| Q2 25 | — | $3.67 | ||
| Q1 25 | $-0.02 | $2.56 | ||
| Q4 24 | $0.00 | $1.73 | ||
| Q3 24 | $-0.10 | $0.36 | ||
| Q2 24 | — | $2.48 | ||
| Q1 24 | $0.14 | $1.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.5M | $69.2M |
| 总债务越低越好 | — | $569.1M |
| 股东权益账面价值 | $288.3M | — |
| 总资产 | $734.9M | $969.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BIOXUAN
| Q4 25 | — | $69.2M | ||
| Q3 25 | $15.5M | $156.2M | ||
| Q2 25 | — | $114.4M | ||
| Q1 25 | $38.5M | $121.8M | ||
| Q4 24 | $29.2M | $90.9M | ||
| Q3 24 | $32.3M | $110.5M | ||
| Q2 24 | — | $47.5M | ||
| Q1 24 | $16.4M | $64.6M |
总债务BIOXUAN
| Q4 25 | — | $569.1M | ||
| Q3 25 | — | $569.1M | ||
| Q2 25 | — | $569.2M | ||
| Q1 25 | — | $569.3M | ||
| Q4 24 | — | $568.0M | ||
| Q3 24 | — | $547.7M | ||
| Q2 24 | — | $547.6M | ||
| Q1 24 | — | $547.4M |
股东权益BIOXUAN
| Q4 25 | — | — | ||
| Q3 25 | $288.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $345.0M | — | ||
| Q4 24 | $346.3M | — | ||
| Q3 24 | $346.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $348.5M | — |
总资产BIOXUAN
| Q4 25 | — | $969.5M | ||
| Q3 25 | $734.9M | $1.0B | ||
| Q2 25 | — | $998.0M | ||
| Q1 25 | $798.2M | $1.0B | ||
| Q4 24 | $835.2M | $1.0B | ||
| Q3 24 | $827.3M | $986.6M | ||
| Q2 24 | — | $959.4M | ||
| Q1 24 | $836.1M | $972.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-21.6M |
| 自由现金流经营现金流 - 资本支出 | — | $-45.2M |
| 自由现金流率自由现金流/营收 | — | -34.5% |
| 资本支出强度资本支出/营收 | — | 18.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $98.8M |
8季度趋势，按日历期对齐
经营现金流BIOXUAN
| Q4 25 | — | $-21.6M | ||
| Q3 25 | $14.4M | $91.7M | ||
| Q2 25 | — | $24.1M | ||
| Q1 25 | $23.3M | $55.4M | ||
| Q4 24 | $-5.4M | $12.8M | ||
| Q3 24 | $5.2M | $86.7M | ||
| Q2 24 | — | $8.6M | ||
| Q1 24 | $-17.4M | $42.4M |
自由现金流BIOXUAN
| Q4 25 | — | $-45.2M | ||
| Q3 25 | — | $80.1M | ||
| Q2 25 | — | $18.4M | ||
| Q1 25 | — | $45.5M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | — | $82.3M | ||
| Q2 24 | — | $2.4M | ||
| Q1 24 | — | $34.3M |
自由现金流率BIOXUAN
| Q4 25 | — | -34.5% | ||
| Q3 25 | — | 49.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 31.9% | ||
| Q4 24 | — | -4.0% | ||
| Q3 24 | — | 65.7% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 26.9% |
资本支出强度BIOXUAN
| Q4 25 | — | 18.0% | ||
| Q3 25 | — | 7.1% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 6.9% | ||
| Q4 24 | — | 13.1% | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | — | 4.6% | ||
| Q1 24 | — | 6.3% |
现金转化率BIOXUAN
| Q4 25 | — | — | ||
| Q3 25 | — | 2.13× | ||
| Q2 25 | — | 0.62× | ||
| Q1 25 | — | 2.04× | ||
| Q4 24 | -8.85× | 0.70× | ||
| Q3 24 | — | 22.78× | ||
| Q2 24 | — | 0.33× | ||
| Q1 24 | -1.78× | 3.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BIOX
暂无分部数据
UAN
| Product UAN | $64.7M | 49% |
| Product Ammonia | $50.5M | 39% |
| Products Other | $8.5M | 7% |
| Product Urea Products | $7.4M | 6% |
